6-methylene-4-pregnene-3,20-dione has been researched along with Adenocarcinoma in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (75.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Marts, SA; Mukherji, S; Padilla, GM; Petrow, V | 2 |
Bergh, A; Daehlin, L; Damber, JE; Landström, M; Petrow, V | 1 |
Petrow, V | 1 |
1 review(s) available for 6-methylene-4-pregnene-3,20-dione and Adenocarcinoma
Article | Year |
---|---|
The dihydrotestosterone (DHT) hypothesis of prostate cancer and its therapeutic implications.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Adenocarcinoma; Animals; Dihydrotestosterone; Humans; Male; Neoplasms, Experimental; Neoplasms, Hormone-Dependent; Progesterone; Prostate; Prostatic Neoplasms; Rats; Testosterone | 1986 |
3 other study(ies) available for 6-methylene-4-pregnene-3,20-dione and Adenocarcinoma
Article | Year |
---|---|
Endocrine dependence of prostatic cancer upon dihydrotestosterone and not upon testosterone.
Topics: Adenocarcinoma; Animals; Cells, Cultured; Dihydrotestosterone; Male; Neoplasm Transplantation; Neoplasms, Hormone-Dependent; Progesterone; Prostatic Neoplasms; Rats; Testosterone | 1984 |
Effects of 6-methylene progesterone on growth, morphology, and blood flow of the Dunning R3327 prostatic adenocarcinoma.
Topics: Adenocarcinoma; Animals; Male; Orchiectomy; Progesterone; Prostatic Neoplasms; Rats; Rats, Inbred F344; Regional Blood Flow | 1992 |
Approaches to prostatic cancer chemotherapy using the Dunning R3327H prostatic adenocarcinoma.
Topics: 5-alpha Reductase Inhibitors; Adenocarcinoma; Animals; Carrier Proteins; Disease Models, Animal; Estramustine; Male; Neoplasm Transplantation; Organ Size; Progesterone; Prostate; Prostatic Neoplasms; Prostatic Secretory Proteins; Rats; Structure-Activity Relationship | 1985 |